Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin J Woollard

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Clinical and Experimental Pharmacology & Physiology|April 7, 2005
Soluble bio-markers in vascular disease: much more than gauges of disease?Kevin J Woollard
Clinical Science (London, England : 1979)|May 15, 2013
Immunological aspects of atherosclerosisKevin J Woollard
Nature Reviews. Cardiology|January 13, 2010
Monocytes in atherosclerosis: subsets and functionsKevin J Woollard, Frederic Geissmann
Current Pharmaceutical Design|January 21, 2011
P-selectin antagonism in inflammatory diseaseKevin J Woollard, Jaye Chin-Dusting
Clinical and Experimental Pharmacology & Physiology|November 26, 2009
High-density lipoprotein: a potent inhibitor of inflammationAndrew J Murphy, Kevin J Woollard
Expert Opinion on Therapeutic Patents|April 30, 2014
Targeting monocyte and macrophage subpopulations for immunotherapy: a patent review (2009 - 2013)William D Jackson, Kevin J Woollard
Kidney International|May 3, 2014
The heterogeneous mononuclear phagocyte system of the kidneyKevin J Woollard, Charles D Pusey
Circulation Research|September 2, 2017
The Endless Summer: Thermoneutrality Prevents Monocytosis and Reduces AtherosclerosisKevin J Woollard, Andrew J Murphy
Inflammation & Allergy Drug Targets|March 14, 2007
Therapeutic targeting of p-selectin in atherosclerosisKevin J Woollard, Jaye Chin-Dusting
Scientific Reports|January 30, 2016
Very-low and low-density lipoproteins induce neutral lipid accumulation and impair migration in monocyte subsetsWilliam D Jackson, Tobias W Weinrich, Kevin J Woollard
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Clinical and Experimental Pharmacology & Physiology|April 7, 2005
Soluble bio-markers in vascular disease: much more than gauges of disease?Kevin J Woollard
Clinical Science (London, England : 1979)|May 15, 2013
Immunological aspects of atherosclerosisKevin J Woollard
Nature Reviews. Cardiology|January 13, 2010
Monocytes in atherosclerosis: subsets and functionsKevin J Woollard, Frederic Geissmann
Current Pharmaceutical Design|January 21, 2011
P-selectin antagonism in inflammatory diseaseKevin J Woollard, Jaye Chin-Dusting
Clinical and Experimental Pharmacology & Physiology|November 26, 2009
High-density lipoprotein: a potent inhibitor of inflammationAndrew J Murphy, Kevin J Woollard
Expert Opinion on Therapeutic Patents|April 30, 2014
Targeting monocyte and macrophage subpopulations for immunotherapy: a patent review (2009 - 2013)William D Jackson, Kevin J Woollard
Kidney International|May 3, 2014
The heterogeneous mononuclear phagocyte system of the kidneyKevin J Woollard, Charles D Pusey
Circulation Research|September 2, 2017
The Endless Summer: Thermoneutrality Prevents Monocytosis and Reduces AtherosclerosisKevin J Woollard, Andrew J Murphy
Inflammation & Allergy Drug Targets|March 14, 2007
Therapeutic targeting of p-selectin in atherosclerosisKevin J Woollard, Jaye Chin-Dusting
Scientific Reports|January 30, 2016
Very-low and low-density lipoproteins induce neutral lipid accumulation and impair migration in monocyte subsetsWilliam D Jackson, Tobias W Weinrich, Kevin J Woollard
Pageof 6